Home › Funds › Dauntless Investment Group, LLC › TOI

Dauntless Investment Group, LLC position in TOI

STARLING ONCOLOGY INC COM

Dauntless Investment Group, LLC reported holding 163,570 shares of TOI (STARLING ONCOLOGY INC COM) in its Q2 2026 13F filing — a position valued at US$888K, representing 0.70% of its reported portfolio and ranking #30 among its reported holdings. Dauntless Investment Group, LLC has disclosed TOI holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

Latest position (Q2 2026)163.57K sh
Reported value held$888.18K
Portfolio Weight0.70%
First reportedQ1 2026
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Dauntless Investment Group, LLC's TOI position evolved

Dauntless Investment Group, LLC first disclosed a stake in TOI in Q1 2026 at 462,057 shares (US$1.4M). Across 2 filings, Dauntless Investment Group, LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 163,570 shares valued at US$888K — a reduction of -298,487 shares quarter over quarter.. Notable position changes include a 65% trim in Q2 2026.

Quarter by quarter

QuarterSharesValueChange
Q1 2026 462.06K $1.42M New
Q2 2026 163.57K $888.18K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TOI and 13F data

TOI (STARLING ONCOLOGY INC COM) is a company whose sector is not yet classified in our data. 64 other funds we track also report a position in TOI — the largest reported positions include JOSH ARNOLD INVESTMENT CONSULTANT, LLC (US$13.4M), WEXFORD CAPITAL LP (US$9.3M), BRC Group Holdings, Inc. (US$4.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TOI

All TOI fund holders →

FAQ

How long has Dauntless Investment Group, LLC held TOI?

Dauntless Investment Group, LLC has disclosed TOI holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

What is Dauntless Investment Group, LLC's current position in TOI?

As of Q2 2026, Dauntless Investment Group, LLC holds 163.57K shares of TOI (STARLING ONCOLOGY INC COM), valued at $888.18K, representing 0.70% of its reported portfolio and ranking #30.

Has Dauntless Investment Group, LLC been buying or selling TOI?

In the latest 13F filing (Q2 2026), Dauntless Investment Group, LLC reduced its position in TOI.

Which other funds hold TOI?

Other major institutional holders of TOI include JOSH ARNOLD INVESTMENT CONSULTANT, LLC, WEXFORD CAPITAL LP, BRC Group Holdings, Inc., among 64 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.